These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 18713750)
1. Potent inhibition and global co-localization implicate the transmembrane Kunitz-type serine protease inhibitor hepatocyte growth factor activator inhibitor-2 in the regulation of epithelial matriptase activity. Szabo R; Hobson JP; List K; Molinolo A; Lin CY; Bugge TH J Biol Chem; 2008 Oct; 283(43):29495-504. PubMed ID: 18713750 [TBL] [Abstract][Full Text] [Related]
2. The protease inhibitor HAI-2, but not HAI-1, regulates matriptase activation and shedding through prostasin. Friis S; Sales KU; Schafer JM; Vogel LK; Kataoka H; Bugge TH J Biol Chem; 2014 Aug; 289(32):22319-32. PubMed ID: 24962579 [TBL] [Abstract][Full Text] [Related]
3. Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1. Kirchhofer D; Peek M; Li W; Stamos J; Eigenbrot C; Kadkhodayan S; Elliott JM; Corpuz RT; Lazarus RA; Moran P J Biol Chem; 2003 Sep; 278(38):36341-9. PubMed ID: 12815039 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of an active zymogen protease: the zymogen form of matriptase is regulated by HAI-1 and HAI-2. Skovbjerg S; Holt-Danborg L; Nonboe AW; Hong Z; Frost ÁK; Schar CR; Thomas CC; Vitved L; Jensen JK; Vogel LK Biochem J; 2020 May; 477(9):1779-1794. PubMed ID: 32338287 [TBL] [Abstract][Full Text] [Related]
5. Roles of functional and structural domains of hepatocyte growth factor activator inhibitor type 1 in the inhibition of matriptase. Kojima K; Tsuzuki S; Fushiki T; Inouye K J Biol Chem; 2008 Feb; 283(5):2478-87. PubMed ID: 18048349 [TBL] [Abstract][Full Text] [Related]
6. Engineering a potent inhibitor of matriptase from the natural hepatocyte growth factor activator inhibitor type-1 (HAI-1) protein. Mitchell AC; Kannan D; Hunter SA; Parra Sperberg RA; Chang CH; Cochran JR J Biol Chem; 2018 Apr; 293(14):4969-4980. PubMed ID: 29386351 [TBL] [Abstract][Full Text] [Related]
8. Differential subcellular localization renders HAI-2 a matriptase inhibitor in breast cancer cells but not in mammary epithelial cells. Chang HH; Xu Y; Lai H; Yang X; Tseng CC; Lai YJ; Pan Y; Zhou E; Johnson MD; Wang JK; Lin CY PLoS One; 2015; 10(3):e0120489. PubMed ID: 25786220 [TBL] [Abstract][Full Text] [Related]
9. Matriptase inhibition by hepatocyte growth factor activator inhibitor-1 is essential for placental development. Szabo R; Molinolo A; List K; Bugge TH Oncogene; 2007 Mar; 26(11):1546-56. PubMed ID: 16983341 [TBL] [Abstract][Full Text] [Related]
10. Purification from human milk of matriptase complexes with secreted serpins: mechanism for inhibition of matriptase other than HAI-1. Tseng IC; Chou FP; Su SF; Oberst M; Madayiputhiya N; Lee MS; Wang JK; Sloane DE; Johnson M; Lin CY Am J Physiol Cell Physiol; 2008 Aug; 295(2):C423-31. PubMed ID: 18550704 [TBL] [Abstract][Full Text] [Related]
11. Tissue distribution and subcellular localizations determine in vivo functional relationship among prostasin, matriptase, HAI-1, and HAI-2 in human skin. Lee SP; Kao CY; Chang SC; Chiu YL; Chen YJ; Chen MG; Chang CC; Lin YW; Chiang CP; Wang JK; Lin CY; Johnson MD PLoS One; 2018; 13(2):e0192632. PubMed ID: 29438412 [TBL] [Abstract][Full Text] [Related]
12. Cleavage of hepatocyte growth factor activator inhibitor-1 by membrane-type MMP-1 activates matriptase. Domoto T; Takino T; Guo L; Sato H Cancer Sci; 2012 Mar; 103(3):448-54. PubMed ID: 22118498 [TBL] [Abstract][Full Text] [Related]
13. Polarized epithelial cells secrete matriptase as a consequence of zymogen activation and HAI-1-mediated inhibition. Wang JK; Lee MS; Tseng IC; Chou FP; Chen YW; Fulton A; Lee HS; Chen CJ; Johnson MD; Lin CY Am J Physiol Cell Physiol; 2009 Aug; 297(2):C459-70. PubMed ID: 19535514 [TBL] [Abstract][Full Text] [Related]
15. Hepatocyte growth factor activator inhibitor type 1 inhibits protease activity and proteolytic activation of human airway trypsin-like protease. Kato M; Hashimoto T; Shimomura T; Kataoka H; Ohi H; Kitamura N J Biochem; 2012 Feb; 151(2):179-87. PubMed ID: 22023801 [TBL] [Abstract][Full Text] [Related]
16. The Kunitz Domain I of Hepatocyte Growth Factor Activator Inhibitor-2 Inhibits Matriptase Activity and Invasive Ability of Human Prostate Cancer Cells. Wu SR; Teng CH; Tu YT; Ko CJ; Cheng TS; Lan SW; Lin HY; Lin HH; Tu HF; Hsiao PW; Huang HP; Chen CH; Lee MS Sci Rep; 2017 Nov; 7(1):15101. PubMed ID: 29118397 [TBL] [Abstract][Full Text] [Related]
17. Crystal structures of matriptase in complex with its inhibitor hepatocyte growth factor activator inhibitor-1. Zhao B; Yuan C; Li R; Qu D; Huang M; Ngo JC J Biol Chem; 2013 Apr; 288(16):11155-64. PubMed ID: 23443661 [TBL] [Abstract][Full Text] [Related]
18. Matriptase Complexes and Prostasin Complexes with HAI-1 and HAI-2 in Human Milk: Significant Proteolysis in Lactation. Lai CH; Lai YJ; Chou FP; Chang HH; Tseng CC; Johnson MD; Wang JK; Lin CY PLoS One; 2016; 11(4):e0152904. PubMed ID: 27043831 [TBL] [Abstract][Full Text] [Related]
19. Regulation of pericellular proteolysis by hepatocyte growth factor activator inhibitor type 1 (HAI-1) in trophoblast cells. Kohama K; Kawaguchi M; Fukushima T; Lin CY; Kataoka H Hum Cell; 2012 Dec; 25(4):100-10. PubMed ID: 23248048 [TBL] [Abstract][Full Text] [Related]
20. Expression of serine protease SNC19/matriptase and its inhibitor hepatocyte growth factor activator inhibitor type 1 in normal and malignant tissues of gastrointestinal tract. Zeng L; Cao J; Zhang X World J Gastroenterol; 2005 Oct; 11(39):6202-7. PubMed ID: 16273651 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]